Johnson & Johnson ( JNJ ) has had a solid 2025 - up ~45% (almost accounting for the total gains made in the past 5 years). The execution and financial numbers have been great too. There is scope for growthI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model v ...